Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Two-Time Pulitzer Prize-Winner Bob Woodward Joins MasterClass to Teach Investigative Journalism
-
Pershing Square Communication on ADP – November 9, 2017
-
AllianceBernstein (AB) Appoints Paul Audet, Shelley Leibowitz and Das Narayandas to Board
-
AllianceBernstein Announces Appointment of Three New Independent Board Directors
-
Addepar Announces Record Third Quarter Performance, Expands Leadership Team
-
Peugeot speeds Opel technology shift to cut emissions
-
Deutsche Telekom still open to T-Mobile deal, raises guidance
-
Tesla (TSLA) May Avoid Tariffs In China - Bernstein (pre-market)
-
UPDATE: Bernstein Upgrades Hain Celestial (HAIN) to Outperform, Selloff Appears Overdone
-
Argo Group Declares Quarterly Cash Dividend of $0.27 Per Share
-
Seth P. Bernstein, President and CEO, to Participate in the 2017 Bank of America Merrill Lynch Future of Financials Conference on November 15
-
Investments weigh on BMW profit as it strives to regain industry lead
-
Noted Economist Campbell Harvey Joins Research Affiliates as Partner and Senior Advisor
-
Walter Baker Relaunches with Innovative E-Commerce Experience
-
Failure of U.S. deal hits Deutsche Telekom shares, growth prospects
-
Wingstop (WING) PT Raised to $36 at Barclays on 3Q Report; 'Continues to Impress with Comps Accelerating'
-
Apple firmly on course for $1 trillion valuation: analysts
-
Pre-Open Movers 11/03: (ANET) (S) (WING) (JACK) Higher (P) (CBL) Lower (more...)
-
Bernstein Upgrades Weatherford International (WFT) to Outperform
-
Republican tax plan a blow to Democratic states, officials say
-
Bel Reports Third Quarter 2017 Results
-
Alexion Pharma (ALXN) Announces New Interim Survival Data on LAL-D Treated with Kanuma (sebelipase alfa)
-
New Interim Data Presented at NASPGHAN 2017 Meeting Show Survival Beyond 1 Year of Age in Infants with LAL-D Treated with Kanuma® (sebelipase alfa)
-
Form 497 Bernstein Fund Inc
-
Form 497 Bernstein Fund Inc
-
Argo Group Reports Third Quarter 2017 Results
-
Acadia Realty Trust Reports Third Quarter 2017 Operating Results
-
National Geographic Announces Multiday Movie Event Ahead of Critically Acclaimed Military Drama The Long Road Home
-
Qualcomm (QCOM) PT Raised to $55 at Bernstein Following 4Q17 Release
-
Cognizant Technology Solutions (CTSH) PT Raised to $90 at Bernstein
-
Estee Lauder (EL) PT Raised to $134 at Bernstein
-
Spirit AeroSystems (SPR) PT Raised to $98 at Bernstein
-
Cognizant to Present at the 4th Annual Bernstein Tech Summit
-
Boston Properties Announces Third Quarter 2017 Results
-
Citrix Executives to Present at Upcoming Investor Conferences
-
Notice Of Filing Of Securities Class Action Against Frontier Communications Corp., Its Senior Executives And Directors, And Underwriters Of Its June 2015 Stock Offerings
-
Apple X factor: China buyers rapt by new iPhone, but will they buy?
-
Extend Fertility Brings on Advertising Hall of Fame member Linda Kaplan Thaler For Marketing Campaign and Branding Support
-
Under Armour, Inc. (UAA) PT Slashed to $9 at Bernstein
-
Sift Science Launches Digital Trust Platform™ – Holistic Approach Boosts Customer Loyalty and Retention
-
Return Manafort's money, Democrats demand of California Republican
-
Apple could drop Qualcomm components in next year's iPhones, iPads: sources
-
Form 4 CABOT MICROELECTRONICS For: Oct 30 Filed by: ECKSTEIN BERNSTEIN H CAROL
-
Hortonworks to Participate in Upcoming Fourth Quarter 2017 Investor Conferences
-
MasterCard (MA) PT Raised to $166 at Bernstein Ahead of Q3 Print
-
Boeing (BA) PT Raised to $310 at Bernstein
-
New Akzo Nobel boss pursues $30 billion deal with Axalta
-
Merck (MRK) PT Lowered to $64 at Bernstein
-
Akzo Nobel seeks $30 billion merger with smaller U.S. rival Axalta
-
Activist White Tale turns up pressure on Clariant

